Related Experiment Video
Updated: May 1, 2026

Identification of Cyclin-dependent Kinase 1 Specific Phosphorylation Sites by an In Vitro Kinase Assay
Published on: May 3, 2018
Acetylation of cyclin-dependent kinase 5 is mediated by GCN5
Juhyung Lee1, Nuri Yun1, Chiho Kim1
1Department of Systems Biology, Yonsei University College of Life Science and Biotechnology, Seoul 120-749, Republic of Korea.
Abstract:
Cyclin-dependent kinase 5 (CDK5), a member of atypical serine/threonine cyclin-dependent kinase family, plays a crucial role in pathophysiology of neurodegenerative disorders. Its kinase activity and substrate specificity are regulated by several independent pathways including binding with its activator, phosphorylation and S-nitrosylation. In the present study, we report that acetylation of CDK5 comprises an additional posttranslational modification within the cells. Among many candidates, we confirmed that its acetylation is enhanced by GCN5, a member of the GCN5-related N-acetyl-transferase family of histone acetyltransferase. Co-immunoprecipitation assay and fluorescent localization study indicated that GCN5 physically interacts with CDK5 and they are co-localized at the specific nuclear foci. Furthermore, liquid chromatography in conjunction with a mass spectrometry indicated that CDK5 is acetylated at Lys33 residue of ATP binding domain. Considering this lysine site is conserved among a wide range of species and other related cyclin-dependent kinases, therefore, we speculate that acetylation may alter the kinase activity of CDK5 via affecting efficacy of ATP coordination.
Insights
Acetylation is a newly discovered posttranslational modification for cyclin-dependent kinase 5 (CDK5). GCN5 enhances CDK5 acetylation at Lys33, potentially impacting kinase activity.
Area of Science:
- Biochemistry
- Molecular Biology
- Neuroscience
Background:
- Cyclin-dependent kinase 5 (CDK5) is vital in neurodegenerative disease.
- CDK5 activity is regulated by phosphorylation, S-nitrosylation, and activator binding.
Purpose of the Study:
- To investigate acetylation as a novel posttranslational modification of CDK5.
- To identify enzymes regulating CDK5 acetylation.
Main Methods:
- Co-immunoprecipitation assays to confirm protein interactions.
- Fluorescent localization studies for subcellular co-localization.
- Liquid chromatography-mass spectrometry for identifying acetylation sites.
Main Results:
- Acetylation enhances CDK5 modification within cells.
- GCN5, a histone acetyltransferase, interacts with and enhances CDK5 acetylation.
- CDK5 is acetylated at Lys33 in the ATP binding domain.
- Lys33 is conserved across species and related kinases.
Conclusions:
- Acetylation represents a new regulatory mechanism for CDK5.
- GCN5-mediated acetylation of CDK5 at Lys33 may modulate its kinase activity by affecting ATP binding.
Related Concept Videos
Anaphase Promoting Complex
Positive Regulator Molecules
Positive Regulator Molecules
Inhibition of Cdk Activity
Inhibition of CDK Activity
GPCRs Regulate Adenylyl Cylase Activity

